Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemours (CC) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Chemours (CC) over the last 12 years, with Q3 2025 value amounting to $41.0 million.

  • Chemours' Capital Expenditures fell 4605.26% to $41.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $277.0 million, marking a year-over-year decrease of 2823.83%. This contributed to the annual value of $360.0 million for FY2024, which is 270.27% down from last year.
  • According to the latest figures from Q3 2025, Chemours' Capital Expenditures is $41.0 million, which was down 4605.26% from $43.0 million recorded in Q2 2025.
  • In the past 5 years, Chemours' Capital Expenditures ranged from a high of $135.0 million in Q4 2023 and a low of $41.0 million during Q3 2025
  • In the last 5 years, Chemours' Capital Expenditures had a median value of $73.0 million in 2024 and averaged $78.0 million.
  • Per our database at Business Quant, Chemours' Capital Expenditures soared by 10149.25% in 2023 and then plummeted by 4605.26% in 2025.
  • Quarter analysis of 5 years shows Chemours' Capital Expenditures stood at $83.0 million in 2021, then fell by 19.28% to $67.0 million in 2022, then soared by 101.49% to $135.0 million in 2023, then fell by 19.26% to $109.0 million in 2024, then plummeted by 62.39% to $41.0 million in 2025.
  • Its Capital Expenditures was $41.0 million in Q3 2025, compared to $43.0 million in Q2 2025 and $84.0 million in Q1 2025.